James R. Mason - Concepedia

Author

James R. Mason

Also Known As

J Mason, J R Mason, J. Mason, J. R. Mason, J. Ryan Mason, J.R. Mason, JAMES MASON, James Mason, James R Mason, James R. Mason

Publications

Citations

H-Index

Concepts

All Affiliations

Scripps Clinic Scripps MD Anderson Cancer Center University of California San Diego University of Southern California University of California, San Francisco

About

James R. Mason is an author at Scripps Clinic specializing in medicine, hematology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	526
2	Health Sciences	5	5	298
3	Public Health	2	2	154
4	Social Sciences	1	1	42
5	Applied Physiology	1	1	48

James R. Mason

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial Philippe Armand, Arnon Nagler, Edie Weller, Journal of Clinical Oncology	2013	437
CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation Asad Bashey, Bridget Medina, Sue Corringham, Blood	2008	364
Thallium scintigraphy during dobutamine infusion: Nonexercise-dependent screening test for coronary disease James R. Mason, Robert T. Palac, Maynard L. Freeman, American Heart Journal Coronary DiseaseCardiovascular DiseaseThallium ScintigraphyDobutamine InfusionPublic Health	1984	144
Phase 2 study of arsenic trioxide in patients with relapsed or refractory multiple myeloma Mohamad A. Hussein, Mansoor N. Saleh, Farhad Ravandi, British Journal of Haematology ImmunologyPathologyCell DeathMetronomic ChemotherapyImmunotherapy	2004	115
Phase II Multicenter Study of Arsenic Trioxide in Patients With Myelodysplastic Syndromes Gary J. Schiller, James L. Slack, John D. Hainsworth, Journal of Clinical Oncology	2006	106
Evidence of Donor-Derived Hematologic Malignancies after Hematopoietic Stem Cell Transplantation Olga Sala‐Torra, Colleen Hanna, Michael R. Loken, Biology of Blood and Marrow Transplantation ImmunologyPathologyCell Replacement TherapyOncologyStem Cell Transplantation	2006	103
Non-invasive characterization of human bone marrow stimulation and reconstitution by cell-free messenger RNA sequencing Arkaitz Ibarra, Jiali Zhuang, Yue Zhao, Nature Communications	2020	69
Pluripotent and lineage-committed CD34+ subsets in leukapheresis products mobilized by G-CSF, GM-CSF vs. a combination of both. A. D. Ho, D.J. Young, M Maruyama, PubMed	1996	67
The ubiquitin ligase RNF5 determines acute myeloid leukemia growth and susceptibility to histone deacetylase inhibitors Ali Khateb, Anagha Deshpande, Yongmei Feng, Nature Communications	2021	64
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need Naveen Pemmaraju, Hagop M. Kantarjian, Kendra Sweet, Blood	2022	54

Page 1